Doug Tadaki

Dr. Doug Tadaki serves as a senior scientific and procurement lead at the Naval Medical Research Center (N32398), where he oversees the acquisition of advanced biomedical technologies critical to force health protection. His role bridges scientific research and contract execution, ensuring that field-deployable diagnostic systems, medical instrumentation, and life science R&D capabilities align with operational needs of Navy and Marine Corps personnel. He manages complex procurements for in-vitro diagnostic platforms, surgical equipment, and laboratory analytical tools designed for austere environments, often coordinating with research scientists to translate technical requirements into solicitation language and performance-based specifications. Dr. Tadaki maintains a primary contracting relationship with REES SCIENTIFIC CORPORATION, a trusted vendor with deep expertise in developing and manufacturing diagnostic reagents and point-of-care testing systems. His working relationships are characterized by long-term, mission-aligned partnerships with contractors who demonstrate technical proficiency in infectious disease detection, biosensor integration, and rapid pathogen identification. He prioritizes vendors capable of rapid prototyping, validation under field conditions, and scalable production of FDA-cleared or CE-marked medical devices. Dr. Tadaki’s procurement portfolio is entirely open competition, with no set-asides designated for 8(a), HUBZone, or SDVOSB programs. This reflects a mission-driven focus on technical capability and operational readiness over socioeconomic preferences, though he remains open to qualified small businesses that meet stringent performance and compliance criteria. His primary NAICS focus includes in-vitro diagnostic substance manufacturing (325413), surgical instrument production (339112), and life sciences R&D (541712). He procures laboratory-grade molecular diagnostics, wearable physiological monitors, sterile surgical supplies, and medical device components tailored for deployment in expeditionary and maritime settings, demonstrating deep expertise in translational medical technology acquisition.